BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price traded up 6.3% during mid-day trading on Tuesday . The stock traded as high as $15.99 and last traded at $15.96. 893,814 shares changed hands during trading, a decline of 64% from the average session volume of 2,491,820 shares. The stock had previously closed at $15.01. […]
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) have received a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the firm, Marketbeat reports. Nine analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the stock […]
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) have been given a consensus recommendation of “Buy” by the nine analysts that are currently covering the company, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating. The average 1 year price target among brokers that have covered the stock in […]
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) rose 6.8% during mid-day trading on Tuesday . The company traded as high as $15.82 and last traded at $15.60. Approximately 573,840 shares changed hands during trading, a decline of 77% from the average daily volume of 2,492,654 shares. The stock had previously closed at $14.60. […]